Login
$BLTE
$162.56 -$1.79 (1.09%) Live

Insider Transactions

What BELITE BIO, INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 50 179
Total trades 53 184

Shares traded

3 months 12 months
Acquired 0 0
Disposed 0 0
Net activity +0 +0

Common stock only — 184 reported trades in the last 12 months are in a security these totals do not cover.

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Scholl Hendrik Peter Chief Medical Officer Nov 12 Disclosed 10b5-1 sale · S −500 $170.41 −$85.2K 12,500
Scholl Hendrik Peter Chief Medical Officer Nov 12 Disclosed 10b5-1 sale · S −500 $166.82 −$83.4K 13,000
Scholl Hendrik Peter Chief Medical Officer Nov 12 Disclosed 10b5-1 sale · S −500 $164.68 −$82.3K 13,500
Scholl Hendrik Peter Chief Medical Officer Nov 12 Disclosed 10b5-1 sale · S −500 $162.04 −$81K 14,000
Lin Yu-Hsin Chief Executive Officer Oct 29 Other Transaction · J +5,000 — — 187,949
Chuang Hao-Yuan Chief Financial Officer Oct 29 Other Transaction · J +5,000 — — 180,264
Scholl Hendrik Peter Chief Medical Officer Oct 01 Disclosed 10b5-1 sale · S −2 $170.02 −$340 14,500
Scholl Hendrik Peter Chief Medical Officer Oct 01 Disclosed 10b5-1 sale · S −14 $169.36 −$2.37K 14,502
Scholl Hendrik Peter Chief Medical Officer Oct 01 Disclosed 10b5-1 sale · S −12 $168.21 −$2.02K 14,516
Scholl Hendrik Peter Chief Medical Officer Oct 01 Disclosed 10b5-1 sale · S −78 $167.59 −$13.1K 14,528
Scholl Hendrik Peter Chief Medical Officer Oct 01 Disclosed 10b5-1 sale · S −50 $166.44 −$8.32K 14,606
Scholl Hendrik Peter Chief Medical Officer Oct 01 Disclosed 10b5-1 sale · S −120 $165.49 −$19.9K 14,656
Scholl Hendrik Peter Chief Medical Officer Oct 01 Disclosed 10b5-1 sale · S −24 $164.64 −$3.95K 14,776
Scholl Hendrik Peter Chief Medical Officer Oct 01 Disclosed 10b5-1 sale · S −200 $163.63 −$32.7K 14,800
Chen Wan-Shan Director Sep 24 In/At-money Exercise · X +13,796 $0.44 +$6.05K 37,259
Lin Yu-Hsin Chief Executive Officer Sep 08 Disclosed 10b5-1 sale · S −2,700 $198.09 −$535K 70,134
Lin Yu-Hsin Chief Executive Officer Sep 08 Disclosed 10b5-1 sale · S −8,752 $197.36 −$1.73M 72,834
Lin Yu-Hsin Chief Executive Officer Sep 08 Disclosed 10b5-1 sale · S −6,058 $196.54 −$1.19M 81,586
Lin Yu-Hsin Chief Executive Officer Sep 08 Disclosed 10b5-1 sale · S −6,090 $195.62 −$1.19M 87,644
Lin Yu-Hsin Chief Executive Officer Sep 08 Disclosed 10b5-1 sale · S −2,400 $194.33 −$466K 93,734

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support